SMTL ID : 4d0r.1

Mtb InhA complex with Pyradizinone compound 1

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.75 Å

Oligo State

homo-tetramer

Ligands

4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)

NAD.1: 24 residues within 4Å: Chain A: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, M.161, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: 41I.2 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:I.21, A:F.149, A:A.191 Hydrogen bonds: A:G.14, A:I.21, A:D.64, A:D.64, A:V.65, A:I.95, A:G.96, A:K.165, A:I.194, A:I.194, A:T.196 pi-Stacking: A:F.41 NAD.3: 24 residues within 4Å: Chain B: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, M.161, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: 41I.4 15 PLIP interactions: 15 interactions with chain B Hydrophobic interactions: B:I.21, B:F.149, B:A.191 Hydrogen bonds: B:G.14, B:I.21, B:D.64, B:V.65, B:I.95, B:G.96, B:K.165, B:I.194, B:I.194, B:T.196, B:T.196 pi-Stacking: B:F.41 NAD.5: 24 residues within 4Å: Chain C: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, M.161, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: 41I.6 15 PLIP interactions: 15 interactions with chain C Hydrophobic interactions: C:I.21, C:F.149, C:A.191 Hydrogen bonds: C:G.14, C:I.21, C:D.64, C:D.64, C:V.65, C:I.95, C:G.96, C:K.165, C:I.194, C:I.194, C:T.196 pi-Stacking: C:F.41 NAD.7: 24 residues within 4Å: Chain D: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, M.161, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: 41I.8 15 PLIP interactions: 15 interactions with chain D Hydrophobic interactions: D:I.21, D:F.149, D:A.191 Hydrogen bonds: D:G.14, D:I.21, D:D.64, D:V.65, D:I.95, D:G.96, D:K.165, D:I.194, D:I.194, D:T.196, D:T.196 pi-Stacking: D:F.41

4 x 41I: 4-(4-chlorophenoxy)-6-oxo-1-phenyl-1,6-dihydropyridazine-3-carboxamide(Non-covalent)

41I.2: 13 residues within 4Å: Chain A: G.96, M.103, F.149, D.150, M.155, Y.158, A.191, G.192, P.193, I.194, M.199, W.222 Ligands: NAD.1 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:F.149, A:F.149, A:W.222 Water bridges: A:I.194 pi-Stacking: A:F.149, A:Y.158 Halogen bonds: A:D.150 41I.4: 13 residues within 4Å: Chain B: G.96, M.103, F.149, D.150, M.155, Y.158, A.191, G.192, P.193, I.194, M.199, W.222 Ligands: NAD.3 8 PLIP interactions: 8 interactions with chain B Hydrophobic interactions: B:F.149, B:F.149, B:W.222 Hydrogen bonds: B:Y.158 Water bridges: B:I.194 pi-Stacking: B:F.149, B:Y.158 Halogen bonds: B:D.150 41I.6: 13 residues within 4Å: Chain C: G.96, M.103, F.149, D.150, M.155, Y.158, A.191, G.192, P.193, I.194, M.199, W.222 Ligands: NAD.5 7 PLIP interactions: 7 interactions with chain C Hydrophobic interactions: C:F.149, C:F.149, C:W.222 Water bridges: C:I.194 pi-Stacking: C:F.149, C:Y.158 Halogen bonds: C:D.150 41I.8: 13 residues within 4Å: Chain D: G.96, M.103, F.149, D.150, M.155, Y.158, A.191, G.192, P.193, I.194, M.199, W.222 Ligands: NAD.7 8 PLIP interactions: 8 interactions with chain D Hydrophobic interactions: D:F.149, D:F.149, D:W.222 Hydrogen bonds: D:Y.158 Water bridges: D:I.194 pi-Stacking: D:F.149, D:Y.158 Halogen bonds: D:D.150

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lange, S., Pyridazinones: A Novel Scaffold with Excellent Physicochemical Properties and Safety Profile for a Clinically Validated Target of Mycobacterium Tuberculosis. To be Published

Release Date

2015-05-20

Peptides

ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
A

D
A

ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]